Savara so good: Aerovanc inhaled vancomycin nears pivotal with $20M series C March 2, 2016 By Randy Osborne
FDA decisions on Neuro-Spinal Scaffold propel Invivo's INSPIRE study, stock forward March 2, 2016 By Omar Ford
Nexstim facing uncertain future after stroke rehabilitation device trial fails March 2, 2016 By Amanda Pedersen Nexstim Plc faces an uncertain future with its Navigated Brain Therapy (NBT) for stroke rehabilitation after a phase III study of the device failed to meet its primary endpoint. Read More
RSS